You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

regorafenib

Showing 26 - 50 of 321
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, Glioblastoma, IDH-wildtype Trial in Rome (Biomolecular tumor analysis)

Recruiting
  • Glioblastoma
  • Glioblastoma, IDH-wildtype
  • Biomolecular tumor analysis
  • Rome, Italy
    Fondazione Policlinico Universitario A. Gemelli IRCCS
Mar 6, 2023

Called STAR-T to Learn More About Sequential Treatment With

Not yet recruiting
  • Metastatic Colorectal Cancer (mCRC)
  • Regorafenib (BAY73-4506, Stivarga®)
  • +2 more
  • Whippany, New Jersey
    Many locations
Apr 21, 2023

Colo-rectal Cancer, Metastatic Cancer Trial in Besançon, Dijon, Montbéliard (Regorafenib, Cyclophosphamide, Capecitabine)

Active, not recruiting
  • Colo-rectal Cancer
  • Metastatic Cancer
  • Regorafenib
  • +3 more
  • Besançon, France
  • +2 more
Jan 24, 2023

Carcinoma, Hepatocellular, Hepatoma Trial in Seongnam, Seoul (Regorafenib/Nivolumab)

Completed
  • Carcinoma, Hepatocellular
  • Hepatoma
  • Seongnam, Korea, Republic of
  • +2 more
Dec 4, 2022

Osteosarcoma, Osteosarcoma in Children, Osteosarcoma Recurrent Trial in United States (Regorafenib 40 MG, Regorafenib 20MG,

Recruiting
  • Osteosarcoma
  • +3 more
  • Regorafenib 40 MG
  • +2 more
  • Los Angeles, California
  • +7 more
Jan 19, 2023

Hepatocellular Carcinoma Trial in Winston-Salem (TheraBionic, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma
  • TheraBionic
  • Regorafenib
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Oct 26, 2022

Metastatic Colorectal Cancer (mCRC) Trial in France (Regorafenib, Irinotecan)

Recruiting
  • Metastatic Colorectal Cancer (mCRC)
  • Nice, Alpes-Maritimes, France
  • +10 more
Jan 16, 2023

Liver Metastases, Colorectal Cancer Metastatic Trial in Shanghai (Sintilimab, Regorafenib, US/CT-guided Percutaneous

Recruiting
  • Liver Metastases
  • Colorectal Cancer Metastatic
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 8, 2022

Colorectal Cancer, Liver Metastases, MSS Trial (Sinti+Rego+Cele)

Not yet recruiting
  • Colorectal Cancer
  • +2 more
  • (no location specified)
Jul 3, 2023

Advanced Biliary Systemic Tumours That Has Failed at Least One Prior Systemic Therapy Trial in Tianjin (Cadonilimab Injection,

Recruiting
  • Advanced Biliary Systemic Tumours That Has Failed at Least One Prior Systemic Therapy
  • Cadonilimab Injection
  • Regorafenib
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Dec 7, 2022

Colorectal Cancer Trial in Pisa (Regorafenib, Panitumumab)

Recruiting
  • Colorectal Cancer
  • Pisa, PI, Italy
    U.O. Oncologia 2 Universitaria
Aug 3, 2022

Advanced Hepatocellular Carcinoma That Has Failed at Least One Prior Systemic Therapy Trial in Tianjin (Cadonilimab Injection,

Recruiting
  • Advanced Hepatocellular Carcinoma That Has Failed at Least One Prior Systemic Therapy
  • Cadonilimab Injection
  • Regorafenib
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Dec 7, 2022

Colorectal Liver Metastasis Trial in Shanghai (HAIC-FOLFOX combined with Sintilimab and Regorafenib)

Recruiting
  • Colorectal Liver Metastasis
  • HAIC-FOLFOX combined with Sintilimab and Regorafenib
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 1, 2023

Hepatocellular Carcinoma Trial in Seongnam-si, Seoul (regorafenib)

Recruiting
  • Hepatocellular Carcinoma
  • regorafenib
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +1 more
Sep 24, 2022

Called ROCURS, to Learn About COVID-19 Related Outcomes in

Active, not recruiting
  • Malignant Solid Tumors
  • +2 more
  • Whippany, New Jersey
    Bayer
Feb 2, 2023

Advanced Colorectal Adenocarcinoma, Advanced Microsatellite Stable Colorectal Carcinoma, Metastatic Colorectal Adenocarcinoma

Not yet recruiting
  • Advanced Colorectal Adenocarcinoma
  • +5 more
  • Balstilimab
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

Sequential Regorafenib Plus ICIs After HAIC for Advanced

Recruiting
  • Hepatocellular Carcinoma
  • Regorafenib combine with ICIs
  • Guangzhou, Guangdong, China
  • +1 more
Oct 15, 2022

Osteosarcoma, Ewing Sarcoma of Bone Trial in Warsaw (Regorafenib)

Recruiting
  • Osteosarcoma
  • Ewing Sarcoma of Bone
  • Regorafenib
  • Warsaw, Mazovian, Poland
    Mother and Child Institute
Sep 7, 2022

Colorectal Cancer Trial in Omaha (XL092, Atezolizumab, Regorafenib)

Recruiting
  • Colorectal Cancer
  • Omaha, Nebraska
    Exelixis Clinical Site #1
Jul 26, 2022

Colorectal Cancer Metastatic Trial in France (Regorafenib)

Recruiting
  • Colorectal Cancer Metastatic
  • Regorafenib
  • Brest, France
  • +11 more
Dec 7, 2022

Regorafenib, Raltitrexed, Colorectal Tumors Trial (Regorafenib, Raltitrexed)

Not yet recruiting
  • Regorafenib
  • +3 more
  • (no location specified)
Jun 24, 2022

Intrahepatic Cholangiocarcinoma Trial in Tianjin (Regorafenib and HAIC, FOLFOX)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Sep 7, 2022

Metastatic Pancreatic Adenocarcinoma Trial in Cleveland (Regorafenib, Gemcitabine Hydrochloride)

Terminated
Has Results
  • Metastatic Pancreatic Adenocarcinoma
  • Regorafenib
  • Gemcitabine Hydrochloride
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jun 1, 2022

A Real World Study of Regogfinib in HCC

Not yet recruiting
  • Hepatocellular Carcinoma
  • Regorafenib 40 MG
  • (no location specified)
Dec 28, 2022

Learn How and in Which Amount Regorafenib is Given in Usual

Completed
  • Metastatic Colorectal Cancer
  • No intervention
  • Multiple Locations, Spain
    Many Locations
Oct 11, 2022